May 20 2010
GeoVax Labs, Inc. (OTC Bulletin Board: GOVXD), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, is spotlighted on an interactive map posted on the website of Inc. magazine.
The map, created by Nitasha Tiku and April Joyner, is headlined "Incubation Nation: Where Great Ideas Are Born." Tiku and Joyner write: "Spun out of university research labs or started by local entrepreneurs trying to supercharge their hometowns, business incubators are everywhere. This map puts the spotlight on 20 initiatives." Below this is a map of the U.S. with 20 "business incubator" cities labeled.
When users click on Atlanta, Georgia, a text box pops up that reads: "The Georgia Research Alliance, a consortium of six universities, fosters collaboration across different campuses and helps commercialize the results. It has generated more than 150 companies. Who gets in: Advanced computing, multimedia, biotech, and alternative-energy start-ups. Breakout company: In March, GeoVax Labs got the nod from the FDA to test its HIV vaccine in human clinical trials."
Robert T. McNally, GeoVax's president and CEO, commented: "We are pleased that Inc. magazine has chosen to call attention to our HIV vaccine efforts in such a dynamic format. We are confident that our work is on the right track, and are proud to be chosen by the magazine as the most notable 'breakout company' in the Atlanta area."
SOURCE GeoVax Labs, Inc.
UT Health San Antonio leads effort for developing oral vaccine against chlamydia